Visceral Involvements and Long-term Sequelae in Drug-induced Hypersensitivity Syndrome

Medical Clinics of North America

Volumn 94, Issue 4, 2010, Pages 743-759

  Kano, Yoko ^a   Ishida, Tadashi ^a   Hirahara, Kazuhisa ^a   Shiohara, Tetsuo ^a  

^a KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Drug induced hypersensitivity syndrome; Hepatitis; Limbic encephalitis; Renal dysfunction; Sclerodermoid lesion; Systemic lupus erythematosus; Thyroiditis; Type 1 diabetes mellitus

Indexed keywords

ALLOPURINOL; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CORTICOSTEROID; DAPSONE; GANCICLOVIR; MINOCYCLINE; PHENOBARBITAL; PHENYTOIN; PREDNISOLONE; ZONISAMIDE;

ATRIOVENTRICULAR BLOCK; AUTOIMMUNE DISEASE; AUTOIMMUNE THYROIDITIS; CLINICAL FEATURE; DIGESTIVE SYSTEM ULCER; DRESS SYNDROME; EOSINOPHILIA; GASTROINTESTINAL HEMORRHAGE; GRAFT VERSUS HOST REACTION; HEMOPHAGOCYTIC SYNDROME; HEPATITIS; HERPES LABIALIS; HERPES ZOSTER; HUMAN; HUMAN HERPESVIRUS 6; INAPPROPRIATE VASOPRESSIN SECRETION; INSULIN DEPENDENT DIABETES MELLITUS; INTERSTITIAL PNEUMONIA; KIDNEY DYSFUNCTION; KIDNEY FAILURE; LOEFFLER PNEUMONIA; LUNG BULLA; MYOCARDITIS; PANCREATITIS; PAROTID ENLARGEMENT; PLEURISY; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; THYROID DISEASE; VIRUS REACTIVATION;

AUTOIMMUNE DISEASES; DIABETES MELLITUS, TYPE 1; DIGESTIVE SYSTEM DISEASES; DRUG HYPERSENSITIVITY; DRUG-INDUCED LIVER INJURY; HEART DISEASES; HERPESVIRIDAE; HERPESVIRIDAE INFECTIONS; KIDNEY DISEASES; LUNG DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MENINGOENCEPHALITIS; MULTIPLE ORGAN FAILURE; RISK FACTORS; SCLERODERMA, SYSTEMIC; SYNDROME; THYROIDITIS; TIME FACTORS; VIRUS ACTIVATION;

EID: 77953597045     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2010.03.004     Document Type: Review

References (66)

1. Sullivan J.R., and Shear N.H. The drug hypersensitivity syndrome: what is the pathogenesis?. Arch Dermatol 137 3 (2001) 357-364
2. Gennis M.A., Vemuri R., Burns E.A., et al. Familial occurrence of hypersensitivity to phenytoin. Am J Med 91 6 (1991) 631-634
3. Bocquet H., Martine B., and Roujeau J.C. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS). Semin Cutan Med Surg 15 4 (1996) 250-257
4. Descamps V., Bouscarat F., Laglenne S., et al. Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome. Br J Dermatol 137 4 (1997) 605-608
5. Suzuki Y., Inagi R., Aono T., et al. Human herpesvirus 6 infection as a risk factor of the development of severe drug-induced hypersensitivity. Arch Dermatol 134 9 (1998) 1108-1112
6. Tohyama M., Yahata Y., Yasukawa M., et al. Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. Arch Dermatol 134 9 (1998) 1113-1117
7. Hashimoto K., Yasukawa M., and Tohyama M. Human herpesvirus 6 and drug allergy. Curr Opin Allergy Clin Immunol 3 4 (2003) 255-260
8. Shiohara T., Iijima M., Ikezawa Z., et al. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol 156 5 (2007) 1083-1084
9. Ghislain P.D., and Roujeau J.C. Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome. Dermatol online J 8 1 (2002) 5
10. Kano Y., and Shiohara T. The variable clinical picture of drug-induced hypersensitivity syndrome (DIHS)/drug rash with eosinophilia and systemic symptoms (DRESS) in relation to the eliciting drug. Immunol Allergy Clin North Am 29 3 (2009) 481-501
11. Roujeau J.C. Clinical heterogeneity of drug hypersensitivity. Toxicology 209 2 (2005) 123-129
12. Shiohara T., and Kano Y. Complex interaction between drug allergy and viral infection. Clin Rev Allergy Immunol 33 1-2 (2007) 124-133
13. Kano Y., Hirahara K., Sakuma K., et al. Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease. Br J Dermatol 155 2 (2006) 301-306
14. Kano Y., Inaoka M., and Shiohara T. Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia. Arch Dermatol 140 2 (2004) 183-188
15. Carroll M.C., Yueng-Yue K.A., Esterly N.B., et al. Drug-induced hypersensitivity syndrome in pediatric patients. Pediatrics 108 2 (2001) 485-492
16. Callot V., Roujeau J.C., Bagot M., et al. Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entities. Arch Dermatol 132 11 (1996) 1315-1321
17. Rijlaarsdam J.U., Scheffer E., Meijer C.J., et al. Cutaneous pseudo-T cell lymphomas. A clinicopathologic study of 20 patients. Cancer 69 3 (1992) 717-724
18. Kano Y., Hirahara K., Mitsuyama Y., et al. Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and type of drug eruption. Allergy 62 12 (2007) 1439-1444
19. Komatsuda A., Okamoto Y., Hatakeyama T., et al. Sulfasalazine-induced hypersensitivity syndrome and haemophagocytic syndrome associated with reactivation of Epstein-Barr virus. Clin Rheumatol 27 3 (2008) 395-397
20. Shiohara T., Takahashi R., and Kano Y. Drug-induced hypersensitivity syndrome and viral reactivation. In: Pichler W.J. (Ed). Drug hypersensitivity (2007), Karger, Basel 251-266
21. Hari Y., Frutig-Schnyder K., Hurni M., et al. T cell involvement in cutaneous drug eruptions. Clin Exp Allergy 31 9 (2001) 1398-1408
22. Newell B.D., Moinfar M., Mancini A.J., et al. Retrospective analysis of 32 pediatric patients with anticonvulsant hypersensitivity syndrome (ACHSS). Pediatr Dermatol 26 5 (2009) 536-546
23. Shiohara T., Inaoka M., and Kano Y. Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses. Allergol Int 55 1 (2006) 1-8
24. Itha S., Kumar A., Dhingra S., et al. Dapsone induced cholangitis as a part of dapsone syndrome: a case report. BMC Gastroenterol 3 (2003) 21
25. Tohyama M., Hashimoto K., Yasukawa M., et al. Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome. Br J Dermatol 157 5 (2007) 934-940
26. Eshki M., Allanore L., Musset P., et al. Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms. Arch Dermatol 145 1 (2009) 67-72
27. Descloux E., Argaud L., Dumortier J., et al. Favourable issue of a fulminant hepatitis associated with sulfasalazine DRESS syndrome without liver transplantation. Intensive Care Med 31 12 (2005) 1727-1728
28. Mennicke M., Zawodniak A., Keller M., et al. Fulminant liver failure after vancomycin in a sulfasalazine-induced DRESS syndrome: fatal recurrence after liver transplantation. Am J Transplant 9 9 (2009) 2197-2202
29. Roujeau J.C., and Stren R.S. Severe adverse cutaneous reactions to drugs. N Engl J Med 331 19 (1994) 1272-1285
30. Kumar A., Edward N., White M.I., et al. Allopurinol, erythema multiforme, and renal insufficiency. BMJ 312 7024 (1996) 173-174
31. Higuchi M., Agatsuma T., Iizima M., et al. A case of drug-induced hypersensitivity syndrome with multiple organ involvement treated with plasma exchange. Ther Apher Dial 9 5 (2005) 412-416
32. Augusto J.-F., Sayegh J., Simon A., et al. A case of sulphasalazine-induced DRESS syndrome with delayed acute interstitial nephritis. Nephrol Dial Transplant 24 9 (2009) 2940-2942
33. Roca B., Calvo B., and Ferrer D. Minocycline hypersensitivity reaction with acute respiratory distress syndrome. Intensive Care Med 29 2 (2003) 338
34. Lazoglu A.H., Boglioli L.R., Dorsett B., et al. Phenytoin-related immunodeficiency associated with Loeffler's syndrome. Ann Allergy Asthma Immunol 74 6 (1995) 479-482
35. Hetherrington S., McGuirk S., Powell G., et al. Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir. Clin Ther 23 10 (2001) 1603-1614
36. Mallal S., Nolan D., Witt C., et al. Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet 359 9308 (2002) 727-732
37. Sekiguchi A., Kashiwagi T., Ishida-Yamamoto A., et al. Drug-induced hypersensitivity syndrome due to mexiletine associated with human herpesvirus 6 and cytomegalovirus reactivation. J Dermatol 32 4 (2005) 278-281
38. Teo R.Y., Tay Y.K., Tan C.H., et al. Presumed dapson-induced drug hypersensitivity syndrome causing reversible hypersensitivity myocarditis and thyrotoxicosis. Ann Acad Med Singap 35 11 (2006) 833-836
39. Ben m'rad M., Lecler-Mercier S., Blanche P., et al. Drug-induced hypersensitivity syndrome clinical and biologic patterns in 24 patients. Medicine 88 3 (2009) 131-140
40. Zaldi A.N. Anticonvulsant hypersensitivity syndrome leading to reversible myocarditis. Can J Clin Pharmacol 12 1 (2005) e33-e40
41. Zhu K.J., He F.T., Jin N., et al. Complete atrioventricular block associated with dapson therapy: a rare complication of dapson-induced hypersensitivity syndrome. J Clin Pharm Ther 34 4 (2009) 489-492
42. Fujino Y., Nakajima M., Inoue H., et al. Human herpesvirus 6 encephalitis associated with hypersensitivity syndrome. Ann Neurol 51 6 (2002) 771-774
43. Masaki T., Fukunaga A., Tohyama M., et al. Human herpes virus 6 encephalitis in allopurinol-induced hypersensitivity syndrome. Acta Derm Venereol 83 2 (2003) 128-131
44. Sakuma K., Kano Y., Fukuhara M., et al. Syndrome of inappropriate secretion of antidiretic hormone associated with limbic encephalitis in a patient with drug-induced hypersensitivity syndrome. Clin Exp Dermatol 33 3 (2008) 287-290
45. Chik K.W., Chan P.K., Li C.K., et al. Human herpesvirus-6 encephalitis after unrelated umbilical cord blood transplant in children. Bone Marrow Transplant 29 12 (2002) 991-994
46. Wainwright M.S., Martin P.L., Morse R.P., et al. Human herpesvirus 6 limbic encephalitis after stem cell transplantation. Ann Neurol 50 5 (2001) 612-619
47. Gewurtz B.E., Marty F.M., Baden L.R., et al. Human herpesvirus 6 encephalitis. Curr Infect Dis Rep 10 4 (2008) 292-299
48. Asano Y., Kagawa H., Kano Y., et al. Cytomegalovirus disease during severe drug eruptions: report of 2 cases and retrospective study of 18 patients with drug-induced hypersensitivity syndrome. Arch Dermatol 145 9 (2009) 1030-1036
49. Arakawa M., Kakuto Y., Ichikawa K., et al. Allopurinol hypersensitivity syndrome associated with systemic cytomegalovirus infection and systemic bacteremia. Intern Med 40 4 (2001) 331-335
50. Seishima M., Yamanaka S., Fujisawa T., et al. Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome. Br J Dermatol 155 2 (2006) 344-349
51. Seino Y., Yamauchi M., Hirai C., et al. A case of fulminant Type 1 diabetes associated with mexiletine hypersensitivity syndrome. Diabet Med 21 10 (2004) 1156-1157
52. Chiou C.C., Chung W.H., Hung S.I., et al. Fulmimant type 1 diabetes mellitus caused by drug hypersensitivity syndrome with human herpesvirus 6. J Am Acad Dermatol 54 Suppl 2 (2006) S14-S17
53. Sommers L.M., and Schoene R.B. Allopurinol hypersensitivity syndrome associated with pancreatic exocrine abnormalities and new-onset diabetes mellitus. Arch Intern Med 162 10 (2002) 1190-1192
54. Chiou C.C., Yang L.C., Hung S.I., et al. Clinicopathological features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan. J Eur Acad Dermatol Venereol 22 9 (2008) 1044-1049
55. Ozaki N., Miura Y., Sakakibara A., et al. A case of hypersensitivity syndrome induced by methimazole for Graves' disease. Thyroid 15 12 (2005) 1333-1336
56. Brown R.J., Rother K.I., Artman H., et al. Minocycline-induced drug hypersensitivity syndrome followed by multiple autoimmune sequelae. Arch Dermatol 145 1 (2009) 63-66
57. Kano Y., Sakuma K., and Shiohara T. Sclerodermoid graft-versus-host disease-like lesions occurring after drug-induced hypersensitivity syndrome. Br J Dermatol 156 5 (2007) 1061-1063
58. Aota N., and Shiohara T. Viral connection between drug rashes and autoimmune diseases: how autoimmune responses are generated after resolution of drug rashes. Autoimmun Rev 8 6 (2009) 488-494
59. Aota N., Hirahara K., Kano Y., et al. Systemic lupus erythematosus presenting with Kikuchi-Fujimoto's disease as a long-term sequela of drug-induced hypersensitivity syndrome: a possible role of Epstein-Barr virus reactivation. Dermatology 218 3 (2009) 275-277
60. Sekine N., Motokura T., Oki T., et al. Rapid loss of insulin secretion in a patient with fulminant type 1 diabetes mellitus and carbamazepine hypersensitivity syndrome. JAMA 285 9 (2001) 1153-1154
61. Van der Welf N., Kroese F.G.M., Rozing J., et al. Viral infections as potential triggers of type 1 diabetes. Diabetes Metab Res Rev 23 3 (2007) 169-183
62. Tanaka S., Kobayashi T., Nakanishi K., et al. Association of HLA-DQ genotype in autoantibody-negative and rapid-onset type 1 diabetes. Diabetes Care 25 12 (2002) 2302-2307
63. Van den Driessche A., Eenkhoom V., Van Gaal L., et al. Type 1 diabetes and autoimmune polyglandular syndrome: a clinical review. Neth J Med 67 11 (2009) 376-387
64. Jones-Caballero M., Fernandez-Herrera J., Cordoba-Guijarro S., et al. Sclerodermatous graft-versus-host disease after donor leukocyte infusion. Br J Dermatol 139 5 (1998) 889-892
65. Kijima A., Inui S., Nakamura T., et al. Does drug-induced hypersensitivity syndrome elicit bullous pemphigoid?. Allergol Int 57 2 (2008) 181-182
66. Yun S.J., Lee J.B., Kim E.J., et al. Drug rash with eosinophilia and systemic symptoms induced by valproate and carbamazepine: formation of circulating autoantibody against 190-kDa antigen. Acta Derm Venereol 86 3 (2006) 241-244